APA (7th ed.) Citation

MA, L., JIANG, Z., HOU, X., XU, Y., CHEN, Z., ZHANG, S., . . . JI, J. (2024). LA-D-B1, a novel Abemaciclib derivative, exerts anti-breast cancer effects through CDK4/6. Biocell, 48(5), 847. https://doi.org/10.32604/biocell.2024.050868

Chicago Style (17th ed.) Citation

MA, LING, et al. "LA-D-B1, a Novel Abemaciclib Derivative, Exerts Anti-breast Cancer Effects Through CDK4/6." Biocell 48, no. 5 (2024): 847. https://doi.org/10.32604/biocell.2024.050868.

MLA (9th ed.) Citation

MA, LING, et al. "LA-D-B1, a Novel Abemaciclib Derivative, Exerts Anti-breast Cancer Effects Through CDK4/6." Biocell, vol. 48, no. 5, 2024, p. 847, https://doi.org/10.32604/biocell.2024.050868.